URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Louis Constine

Concepts (482)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hodgkin Disease
38
1982
156
7.260
Why?
Neoplasms, Second Primary
17
2000
125
4.340
Why?
Radiotherapy
31
1981
198
4.240
Why?
Radiation Injuries
21
1988
131
4.040
Why?
Neoplasms
21
1981
743
2.750
Why?
Survivors
17
1993
118
2.460
Why?
Sarcoma
5
1992
64
2.360
Why?
Antineoplastic Combined Chemotherapy Protocols
16
1985
436
2.200
Why?
Cardiovascular Diseases
11
2003
275
1.880
Why?
Neoplasms, Radiation-Induced
11
1995
80
1.720
Why?
Stem Cell Transplantation
3
1999
115
1.460
Why?
Neoplasm Recurrence, Local
8
1995
295
1.440
Why?
Soft Tissue Neoplasms
3
1992
46
1.430
Why?
Child
52
1973
4342
1.420
Why?
Radiotherapy Dosage
22
1981
202
1.400
Why?
Lung Neoplasms
6
1985
435
1.340
Why?
Humans
116
1973
37165
1.300
Why?
Aging
5
2006
705
1.250
Why?
Adolescent
45
1981
5044
1.190
Why?
Combined Modality Therapy
24
1984
491
1.170
Why?
Adult
51
1981
11572
1.130
Why?
Breast Neoplasms
8
2008
666
1.030
Why?
Bone Marrow Transplantation
8
1984
201
1.000
Why?
Hematopoietic Stem Cell Transplantation
4
1998
133
1.000
Why?
Whole-Body Irradiation
7
1984
87
0.980
Why?
Young Adult
16
2009
1084
0.940
Why?
Heart
5
1995
239
0.930
Why?
Child, Preschool
31
1973
2737
0.930
Why?
Radiation Oncology
5
2008
18
0.900
Why?
Risk Factors
20
1991
2331
0.870
Why?
Female
69
1973
20222
0.840
Why?
Lymphoma, Large B-Cell, Diffuse
2
2009
80
0.840
Why?
Antineoplastic Agents
11
1985
628
0.810
Why?
Male
57
1973
20139
0.800
Why?
Brain Neoplasms
5
1987
282
0.800
Why?
Central Nervous System Neoplasms
2
1999
21
0.790
Why?
Fractures, Spontaneous
1
2010
14
0.770
Why?
Cell Aging
2
2010
55
0.750
Why?
Leg
1
2010
99
0.740
Why?
Graft vs Host Disease
3
1999
95
0.720
Why?
Radiosurgery
1
2011
73
0.720
Why?
Cell Transformation, Neoplastic
2
2010
138
0.720
Why?
Bone Density
1
2010
114
0.720
Why?
Incidence
10
1995
682
0.710
Why?
Radiation Tolerance
9
1981
89
0.680
Why?
Middle Aged
30
1987
10013
0.670
Why?
Anthracyclines
5
2007
17
0.670
Why?
DNA Repair
1
2010
173
0.650
Why?
Heart Diseases
4
1995
138
0.640
Why?
Neoplasm Staging
12
1985
354
0.620
Why?
Dose-Response Relationship, Radiation
14
1984
216
0.600
Why?
Practice Guidelines as Topic
4
2008
319
0.590
Why?
Skin Diseases
1
2008
121
0.590
Why?
Follow-Up Studies
16
1984
1889
0.580
Why?
Aged
19
1987
7392
0.580
Why?
Tomography, X-Ray Computed
8
1988
785
0.580
Why?
Leukemia, Myeloid, Acute
1
2008
183
0.570
Why?
Stereotaxic Techniques
1
2006
33
0.560
Why?
Radiology
3
1992
29
0.560
Why?
Time Factors
15
1982
3234
0.560
Why?
Disease
1
2006
36
0.550
Why?
Risk Assessment
8
2004
875
0.540
Why?
Dose Fractionation
4
2006
57
0.540
Why?
Liver Neoplasms
2
2006
155
0.540
Why?
Survival Analysis
10
1993
589
0.540
Why?
Survival Rate
13
1990
619
0.540
Why?
Thyroid Neoplasms
5
1995
69
0.530
Why?
Transplantation, Autologous
7
1984
151
0.520
Why?
Diagnostic Imaging
5
1995
86
0.520
Why?
Infant
13
1981
2320
0.520
Why?
Glioma
2
1987
105
0.510
Why?
Amifostine
4
1985
28
0.490
Why?
Hypothyroidism
6
1982
42
0.480
Why?
Bone Marrow
6
1984
292
0.480
Why?
Treatment Outcome
12
1996
2671
0.470
Why?
Antibiotics, Antineoplastic
3
1993
49
0.470
Why?
Optic Nerve Neoplasms
1
2003
2
0.460
Why?
Neurofibromatosis 1
1
2003
7
0.460
Why?
Endocrine System Diseases
3
1997
13
0.440
Why?
Salvage Therapy
3
2009
62
0.430
Why?
Recurrence
6
1997
697
0.420
Why?
Thyroid Gland
3
1993
54
0.410
Why?
Medical Oncology
2
1992
49
0.390
Why?
Radiation-Protective Agents
3
1986
41
0.390
Why?
Population Surveillance
4
2001
144
0.390
Why?
Prognosis
9
1996
1078
0.370
Why?
Antibodies, Monoclonal, Murine-Derived
2
2009
132
0.360
Why?
Cyclophosphamide
6
1998
177
0.360
Why?
Models, Statistical
3
2010
222
0.360
Why?
Thymus Gland
2
2010
144
0.350
Why?
Rhabdoid Tumor
1
1999
5
0.350
Why?
Ventriculoperitoneal Shunt
1
1999
12
0.350
Why?
Peritoneal Neoplasms
1
1999
25
0.340
Why?
Pituitary Neoplasms
2
1989
66
0.330
Why?
Hypothalamo-Hypophyseal System
2
1995
55
0.320
Why?
Neoadjuvant Therapy
2
2007
32
0.310
Why?
Lung Diseases
3
2006
224
0.310
Why?
Age Distribution
4
2010
227
0.310
Why?
Sex Factors
7
1975
613
0.310
Why?
Retrospective Studies
8
1985
2302
0.300
Why?
Age Factors
9
1973
1152
0.300
Why?
Organothiophosphorus Compounds
2
1986
8
0.300
Why?
Models, Biological
4
1988
1029
0.290
Why?
Severity of Illness Index
3
1995
943
0.290
Why?
Methotrexate
3
1990
73
0.290
Why?
Transplantation, Homologous
4
1999
280
0.280
Why?
Cell Proliferation
2
2010
520
0.270
Why?
Rhabdomyosarcoma
1
1995
12
0.270
Why?
Cranial Irradiation
3
1990
13
0.270
Why?
Magnetic Resonance Imaging
5
1988
1019
0.260
Why?
Medulloblastoma
3
1987
20
0.260
Why?
Thyroid Diseases
1
1995
20
0.260
Why?
Cerebellar Neoplasms
3
1987
23
0.260
Why?
Siblings
2
2010
36
0.260
Why?
Fibroblast Growth Factor 2
3
1998
85
0.260
Why?
Lymphoma, Non-Hodgkin
2
1997
113
0.260
Why?
Lymphoma
2
1998
163
0.250
Why?
Clinical Trials as Topic
6
1985
685
0.250
Why?
Doxorubicin
4
1990
105
0.250
Why?
Disease-Free Survival
6
1998
204
0.240
Why?
Radiation Dosage
6
1993
122
0.240
Why?
Head and Neck Neoplasms
1
1995
84
0.240
Why?
Radiotherapy, Adjuvant
3
1998
74
0.230
Why?
Morbidity
2
2009
73
0.220
Why?
Bone Development
2
1987
87
0.220
Why?
Pituitary Gland
1
1993
62
0.220
Why?
Hypothalamus
1
1993
89
0.220
Why?
Gonadal Disorders
1
2012
1
0.220
Why?
Reproductive Health
1
2012
1
0.220
Why?
Guideline Adherence
2
2010
87
0.220
Why?
Gastrointestinal Neoplasms
1
2012
21
0.220
Why?
Hyperprolactinemia
2
1987
7
0.220
Why?
Vincristine
3
1990
61
0.210
Why?
Echocardiography
2
1993
217
0.210
Why?
Brain
2
1988
1228
0.210
Why?
Carcinoma, Ductal, Breast
2
2008
40
0.210
Why?
Quality Assurance, Health Care
2
2009
130
0.210
Why?
Histiocytoma, Malignant Fibrous
1
2011
5
0.200
Why?
Colony-Forming Units Assay
1
1991
38
0.200
Why?
Sarcoma, Synovial
1
2011
7
0.200
Why?
Leiomyosarcoma
1
2011
18
0.200
Why?
Aged, 80 and over
5
1992
2588
0.200
Why?
United States
7
1992
2847
0.190
Why?
Databases, Factual
2
1999
159
0.190
Why?
Remission Induction
2
1997
165
0.190
Why?
Adiposity
1
2010
11
0.190
Why?
Growth Plate
2
2001
146
0.190
Why?
Weight-Bearing
1
2010
47
0.190
Why?
Cytoprotection
1
2010
40
0.190
Why?
Carcinoma, Non-Small-Cell Lung
1
2011
70
0.190
Why?
Prednisone
2
1998
182
0.190
Why?
Predictive Value of Tests
5
1999
609
0.180
Why?
Meta-Analysis as Topic
1
2010
36
0.180
Why?
Information Dissemination
1
2010
24
0.180
Why?
Clinical Protocols
1
2010
107
0.180
Why?
Osteonecrosis
1
2010
24
0.180
Why?
Interleukin-1
1
1991
221
0.180
Why?
Chemotherapy, Adjuvant
2
1996
88
0.180
Why?
Testicular Neoplasms
1
2010
55
0.180
Why?
Infertility
2
2006
22
0.180
Why?
Brain Injuries
1
2011
108
0.180
Why?
Chronic Disease
2
1991
554
0.180
Why?
Thyroid Hormones
2
1984
35
0.180
Why?
Intelligence
1
1990
111
0.180
Why?
Antibodies, Monoclonal
3
1985
748
0.170
Why?
Craniopharyngioma
1
1989
5
0.170
Why?
Fractures, Bone
1
2010
98
0.170
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1990
82
0.170
Why?
Health Status
1
2012
306
0.170
Why?
Homeostasis
1
2010
177
0.170
Why?
Splenectomy
1
2008
39
0.170
Why?
Abdominal Neoplasms
1
2008
17
0.170
Why?
DNA Damage
1
2010
164
0.170
Why?
Leukemia
2
1999
158
0.170
Why?
Carmustine
4
1987
37
0.160
Why?
Biopsy, Fine-Needle
1
2008
20
0.160
Why?
Carcinoid Tumor
1
2008
27
0.160
Why?
Carcinoma in Situ
1
2008
40
0.160
Why?
Neoplasm Metastasis
2
1985
229
0.160
Why?
Analysis of Variance
2
1999
749
0.160
Why?
Adenoma
1
2008
56
0.160
Why?
Glioblastoma
3
1988
63
0.160
Why?
Statistics as Topic
1
2008
189
0.160
Why?
Quality of Life
3
2005
528
0.160
Why?
Etoposide
5
1998
83
0.150
Why?
Regeneration
2
1984
61
0.150
Why?
Razoxane
1
2007
8
0.150
Why?
Biomedical Research
1
2009
137
0.150
Why?
Patient Care Planning
1
2007
75
0.150
Why?
SEER Program
3
2010
55
0.150
Why?
Chelating Agents
1
2007
66
0.150
Why?
Pediatrics
1
1992
443
0.150
Why?
Aging, Premature
1
2006
7
0.150
Why?
Tumor Burden
1
2006
22
0.140
Why?
Radiotherapy, Computer-Assisted
1
2006
15
0.140
Why?
Delivery of Health Care
1
2008
157
0.140
Why?
Leukemia, Myeloid
1
2007
121
0.140
Why?
Cohort Studies
4
2007
984
0.140
Why?
Odds Ratio
3
2010
323
0.140
Why?
Oxidative Stress
1
2010
347
0.140
Why?
Transplantation Conditioning
2
1999
36
0.140
Why?
Cartilage
1
1987
165
0.140
Why?
Foundations
1
2005
11
0.130
Why?
Myelodysplastic Syndromes
1
2007
132
0.130
Why?
Apoptosis
2
2002
855
0.130
Why?
Radiotherapy Planning, Computer-Assisted
3
2008
48
0.130
Why?
Nervous System Diseases
1
2006
148
0.120
Why?
Thyrotropin
3
1982
32
0.120
Why?
Skin
1
1987
384
0.120
Why?
Adenocarcinoma
1
2008
483
0.120
Why?
Cardiomyopathies
2
1993
80
0.120
Why?
Puberty, Precocious
2
1995
4
0.120
Why?
Ventricular Function, Left
2
1990
86
0.120
Why?
Hematopoietic Stem Cells
4
1984
200
0.120
Why?
Animals
15
1981
16416
0.120
Why?
Coronary Disease
2
1995
257
0.120
Why?
Optic Chiasm
1
2003
7
0.120
Why?
Cognition Disorders
1
2007
291
0.110
Why?
Prostatic Neoplasms
2
1985
540
0.110
Why?
Mediastinum
1
2003
20
0.110
Why?
Stomatitis
2
1999
16
0.110
Why?
Infant, Newborn
5
1981
1836
0.110
Why?
Fibrosis
2
1995
65
0.110
Why?
Visual Pathways
1
2003
77
0.110
Why?
Pentoxifylline
1
2002
27
0.100
Why?
Mental Disorders
1
2006
351
0.100
Why?
Myocardial Infarction
3
1996
651
0.100
Why?
Platinum Compounds
2
2010
7
0.100
Why?
Rabbits
4
1984
720
0.100
Why?
European Continental Ancestry Group
2
1996
238
0.100
Why?
Infertility, Male
2
2010
35
0.100
Why?
Growth
1
1981
39
0.100
Why?
Astrocytoma
2
1988
30
0.100
Why?
Transforming Growth Factor beta
2
1998
411
0.100
Why?
Myocardium
2
1995
319
0.090
Why?
Hyperthyroidism
2
1982
24
0.090
Why?
Dose-Response Relationship, Drug
4
1987
1142
0.090
Why?
Coronary Artery Disease
2
2010
88
0.090
Why?
Exercise Test
2
1993
99
0.090
Why?
Nifedipine
1
1999
33
0.090
Why?
Parenteral Nutrition
1
1999
24
0.090
Why?
Ring Chromosomes
1
1999
4
0.090
Why?
Cytarabine
3
1998
93
0.090
Why?
Methylprednisolone
1
1999
46
0.090
Why?
Chromosomes, Human, Pair 22
1
1999
12
0.090
Why?
Mouth Mucosa
1
1999
44
0.090
Why?
Cyclosporine
1
1999
66
0.090
Why?
Models, Animal
2
2010
140
0.090
Why?
Calcium Signaling
1
2002
191
0.090
Why?
Calcium Channel Blockers
1
1999
69
0.090
Why?
Case-Control Studies
2
2010
624
0.090
Why?
Pituitary Hormones
2
1995
13
0.080
Why?
Research
2
2010
185
0.080
Why?
Chondrocytes
1
2002
303
0.080
Why?
Genetic Predisposition to Disease
2
2010
317
0.080
Why?
Cause of Death
3
1990
158
0.080
Why?
Exercise Tolerance
1
1997
12
0.080
Why?
Diastole
1
1997
24
0.080
Why?
Immunosuppressive Agents
1
1999
206
0.080
Why?
Radiation Pneumonitis
2
2007
43
0.080
Why?
Bone Neoplasms
2
1985
208
0.080
Why?
Risk
2
2007
355
0.080
Why?
Bleomycin
3
1990
47
0.080
Why?
Fatigue
2
2007
124
0.080
Why?
Neovascularization, Physiologic
1
1998
129
0.080
Why?
Stroke Volume
1
1997
144
0.070
Why?
Gene Expression Regulation
1
2002
895
0.070
Why?
Evidence-Based Medicine
2
2004
210
0.070
Why?
Reproducibility of Results
2
2008
903
0.070
Why?
Ploidies
1
1995
18
0.070
Why?
Multicenter Studies as Topic
1
1996
127
0.070
Why?
Genes, myc
1
1995
28
0.070
Why?
Drug Resistance, Multiple
1
1995
30
0.070
Why?
Pituitary Hormones, Anterior
1
1995
5
0.070
Why?
Pericardium
1
1995
17
0.070
Why?
Genes, Tumor Suppressor
1
1995
49
0.070
Why?
Follicle Stimulating Hormone
1
1995
52
0.070
Why?
African Continental Ancestry Group
1
1996
125
0.070
Why?
Growth Hormone
1
1995
103
0.060
Why?
Luteinizing Hormone
1
1995
60
0.060
Why?
Bone and Bones
1
1998
360
0.060
Why?
Adrenocorticotropic Hormone
1
1995
76
0.060
Why?
Injury Severity Score
1
1995
73
0.060
Why?
Proportional Hazards Models
2
1996
426
0.060
Why?
Neuroblastoma
2
1985
95
0.060
Why?
Cell Cycle
1
1995
253
0.060
Why?
Prospective Studies
3
1993
1696
0.060
Why?
Mice
7
1981
6206
0.060
Why?
Randomized Controlled Trials as Topic
1
1996
415
0.060
Why?
Gonads
1
1993
6
0.060
Why?
Supratentorial Neoplasms
1
1993
8
0.060
Why?
Hypogonadism
1
1993
14
0.060
Why?
Adrenal Glands
1
1993
52
0.060
Why?
Positron-Emission Tomography and Computed Tomography
1
2012
1
0.060
Why?
Multivariate Analysis
2
1990
548
0.050
Why?
Semen Preservation
1
2012
2
0.050
Why?
Puberty, Delayed
1
2012
3
0.050
Why?
Procarbazine
1
2012
12
0.050
Why?
Sexual Dysfunction, Physiological
1
2012
12
0.050
Why?
Laparotomy
1
1992
37
0.050
Why?
Cryopreservation
1
2012
26
0.050
Why?
Natriuretic Peptide, Brain
1
2012
11
0.050
Why?
Canada
1
2012
77
0.050
Why?
Radiotherapy, Intensity-Modulated
1
2012
7
0.050
Why?
Acute Disease
2
2000
591
0.050
Why?
Confounding Factors (Epidemiology)
1
2012
60
0.050
Why?
Radiotherapy, Conformal
1
2012
19
0.050
Why?
Confidence Intervals
1
2012
164
0.050
Why?
Age of Onset
1
2012
126
0.050
Why?
Kaplan-Meier Estimate
1
2012
207
0.050
Why?
Cholesterol
1
2012
137
0.050
Why?
Heart Block
1
2012
59
0.050
Why?
Matched-Pair Analysis
1
2011
15
0.050
Why?
Parathyroid Hormone-Related Protein
2
2001
105
0.050
Why?
Outcome and Process Assessment (Health Care)
1
1992
90
0.050
Why?
Tumor Stem Cell Assay
1
1991
24
0.050
Why?
Testosterone
1
2012
163
0.050
Why?
Carcinoma, Lobular
1
2011
24
0.050
Why?
C-Reactive Protein
1
2012
117
0.050
Why?
Pancytopenia
1
2010
14
0.050
Why?
Maximum Tolerated Dose
1
2010
18
0.050
Why?
Melphalan
1
2010
28
0.050
Why?
Mucositis
1
2010
14
0.050
Why?
Peripheral Blood Stem Cell Transplantation
1
2010
21
0.050
Why?
Granulocytes
1
1991
83
0.050
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2011
39
0.050
Why?
Lymph Nodes
1
1992
215
0.050
Why?
Polymorphism, Genetic
1
2012
200
0.050
Why?
Paresthesia
1
2010
18
0.050
Why?
Genome-Wide Association Study
1
2010
23
0.050
Why?
Radioactive Fallout
1
2010
2
0.050
Why?
Colorectal Neoplasms
1
2012
143
0.050
Why?
Renal Insufficiency
1
2010
20
0.050
Why?
Pericarditis
1
2010
13
0.050
Why?
Coronary Circulation
1
1990
93
0.050
Why?
Injections, Spinal
1
1990
26
0.050
Why?
Employment
1
2010
70
0.050
Why?
Hypertrophy
1
2010
71
0.050
Why?
Societies, Medical
1
2011
142
0.050
Why?
Peptide Fragments
1
2012
307
0.050
Why?
Arrhythmias, Cardiac
1
2012
237
0.040
Why?
Stroke
1
2012
138
0.040
Why?
Prednisolone
1
2009
25
0.040
Why?
Organ Specificity
1
2010
165
0.040
Why?
Adipose Tissue
1
2010
138
0.040
Why?
Pulmonary Fibrosis
1
2010
139
0.040
Why?
Atrial Fibrillation
1
2010
112
0.040
Why?
Postoperative Complications
2
1992
764
0.040
Why?
Forecasting
1
2010
188
0.040
Why?
Body Mass Index
1
2010
229
0.040
Why?
Translational Medical Research
1
2009
38
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2001
543
0.040
Why?
Radiobiology
1
2008
10
0.040
Why?
Disease Progression
1
2011
533
0.040
Why?
Biological Markers
1
2012
564
0.040
Why?
Occupational Exposure
1
2010
114
0.040
Why?
Proteins
2
2001
470
0.040
Why?
Radiation Injuries, Experimental
1
1988
89
0.040
Why?
Rats
2
1981
4389
0.040
Why?
Cognition
1
2010
232
0.040
Why?
Spinal Cord
1
1988
168
0.040
Why?
Leukemia, Radiation-Induced
1
2007
11
0.040
Why?
Palliative Care
2
1985
161
0.040
Why?
Topoisomerase II Inhibitors
1
2007
8
0.040
Why?
Antineoplastic Agents, Alkylating
1
2007
44
0.040
Why?
Time
1
2007
47
0.040
Why?
Meningeal Neoplasms
1
1987
51
0.040
Why?
Meningioma
1
1987
53
0.040
Why?
Osteosarcoma
1
2007
71
0.040
Why?
Reference Values
1
2007
453
0.030
Why?
Italy
1
2005
23
0.030
Why?
Radiation-Sensitizing Agents
2
1982
74
0.030
Why?
Mice, Inbred C57BL
1
1991
1700
0.030
Why?
Sarcoma, Ewing
1
1985
10
0.030
Why?
Wilms Tumor
1
1985
12
0.030
Why?
Antigens, Neoplasm
1
1986
109
0.030
Why?
Nursing Care
1
2004
15
0.030
Why?
Congenital Abnormalities
1
1985
36
0.030
Why?
Skin Physiological Phenomena
2
1973
19
0.030
Why?
Enzyme Inhibitors
1
2007
441
0.030
Why?
Thyroxine
1
1984
45
0.030
Why?
RNA, Messenger
2
2001
1893
0.030
Why?
Joints
2
1973
63
0.030
Why?
Kidney Neoplasms
1
1985
104
0.030
Why?
Cell Separation
1
1984
230
0.030
Why?
Nitroimidazoles
1
1982
11
0.030
Why?
Longitudinal Studies
1
2004
413
0.030
Why?
Neck
1
1982
35
0.030
Why?
Genes, bcl-2
1
2002
22
0.030
Why?
Drug Evaluation, Preclinical
1
2002
79
0.030
Why?
Research Design
1
2004
340
0.030
Why?
Chick Embryo
1
2002
192
0.030
Why?
Receptors, Parathyroid Hormone
1
2001
14
0.030
Why?
Receptor, Parathyroid Hormone, Type 1
1
2001
24
0.030
Why?
Cytosol
1
2002
196
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2002
116
0.020
Why?
Sodium Pertechnetate Tc 99m
1
2000
10
0.020
Why?
Chickens
1
2001
310
0.020
Why?
Radiopharmaceuticals
1
2000
49
0.020
Why?
Myeloablative Agonists
1
2000
6
0.020
Why?
Nuclear Family
1
2000
13
0.020
Why?
Drug Toxicity
1
2000
17
0.020
Why?
Drug Evaluation
1
2000
99
0.020
Why?
Blood Grouping and Crossmatching
1
2000
32
0.020
Why?
Protein Biosynthesis
1
2002
257
0.020
Why?
Anemia, Aplastic
1
1999
24
0.020
Why?
Wiskott-Aldrich Syndrome
1
1999
9
0.020
Why?
DNA Primers
1
2001
422
0.020
Why?
Life Tables
1
1999
38
0.020
Why?
Gestational Age
1
1981
333
0.020
Why?
Fetus
1
1981
247
0.020
Why?
Diarrhea
1
1999
65
0.020
Why?
Graft Survival
1
2000
151
0.020
Why?
Hematologic Neoplasms
1
1999
34
0.020
Why?
Cell Division
1
2002
773
0.020
Why?
Lymphotoxin-alpha
1
1998
10
0.020
Why?
Laser-Doppler Flowmetry
1
1998
20
0.020
Why?
Carcinoma
1
2000
194
0.020
Why?
Drug Therapy, Combination
1
1999
397
0.020
Why?
Mice, Inbred BALB C
3
1982
625
0.020
Why?
Mice, Inbred C3H
1
1998
237
0.020
Why?
Regional Blood Flow
1
1998
186
0.020
Why?
Neoplasm, Residual
1
1997
21
0.020
Why?
Base Sequence
1
2001
1721
0.020
Why?
Pilot Projects
2
1985
446
0.020
Why?
Karnofsky Performance Status
1
1996
14
0.020
Why?
Information Systems
1
1996
18
0.020
Why?
Movement
2
1973
168
0.020
Why?
Hematopoietic Cell Growth Factors
1
1995
15
0.020
Why?
Bone Marrow Diseases
1
1995
44
0.020
Why?
Fluorescent Antibody Technique
2
1985
307
0.020
Why?
Calcium
1
2002
1135
0.020
Why?
Dogs
1
1995
492
0.020
Why?
Terminology as Topic
1
1995
108
0.020
Why?
Tumor Necrosis Factor-alpha
1
1998
694
0.010
Why?
Immunoglobulin G
2
1985
494
0.010
Why?
Gallium Radioisotopes
1
1992
8
0.010
Why?
Evaluation Studies as Topic
1
1992
247
0.010
Why?
Postoperative Period
1
1992
89
0.010
Why?
Neoplasm Invasiveness
1
1992
160
0.010
Why?
Biopsy
1
1992
384
0.010
Why?
Vinblastine
1
1990
27
0.010
Why?
Spleen
1
1992
343
0.010
Why?
Dacarbazine
1
1990
21
0.010
Why?
Heart Function Tests
1
1990
31
0.010
Why?
Surgical Procedures, Operative
1
1992
116
0.010
Why?
Drug Administration Schedule
1
1990
374
0.010
Why?
Sensitivity and Specificity
1
1992
914
0.010
Why?
Electrocardiography
1
1993
746
0.010
Why?
Liver
1
1992
884
0.010
Why?
Hybridomas
1
1986
62
0.010
Why?
Antigen-Antibody Complex
1
1986
56
0.010
Why?
Premedication
1
1985
21
0.010
Why?
Carcinoma, Small Cell
1
1985
33
0.010
Why?
Myeloma Proteins
1
1985
11
0.010
Why?
Urinary Tract
1
1985
9
0.010
Why?
Binding Sites, Antibody
1
1985
34
0.010
Why?
Antibody-Dependent Cell Cytotoxicity
1
1985
28
0.010
Why?
Centrifugation
1
1984
45
0.010
Why?
Erythrocyte Count
1
1984
26
0.010
Why?
Skinfold Thickness
2
1973
8
0.010
Why?
London
2
1973
19
0.010
Why?
Complement System Proteins
1
1985
114
0.010
Why?
Leukocyte Count
1
1984
162
0.010
Why?
Elasticity
2
1973
81
0.010
Why?
Immunoenzyme Techniques
1
1985
214
0.010
Why?
Central Nervous System
1
1985
117
0.010
Why?
Bone Marrow Cells
1
1985
222
0.010
Why?
Lung
1
1990
1148
0.010
Why?
Cell Survival
1
1985
559
0.010
Why?
Etanidazole
1
1982
24
0.010
Why?
Chemistry, Pharmaceutical
1
1982
22
0.010
Why?
Injections, Intravenous
1
1982
133
0.010
Why?
Administration, Oral
1
1982
314
0.010
Why?
Cell Line
1
1986
1623
0.010
Why?
Kinetics
1
1982
1471
0.010
Why?
Metacarpus
1
1975
4
0.000
Why?
Elbow
1
1975
16
0.000
Why?
Knee
1
1975
23
0.000
Why?
Ankle
1
1975
23
0.000
Why?
Finger Joint
1
1975
28
0.000
Why?
Wrist
1
1975
49
0.000
Why?

Visualizations


Constine's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department